The Early Clinical Response of TNF-Alpha Blockers Is a Predictor of Metrology Outcome in Ankylosing Spondylitis.

被引：0

作者：

Nam, Eon Jeong ^{[1
]}

Eun, Jung Soo ^{[1
]}

Kim, Na Ri ^{[1
]}

Kang, Jong Wan ^{[1
]}

Im, Churl Hyun ^{[1
]}

Kang, Young Mo ^{[1
]}

机构：

[1] Kyungpook Natl Univ Sch Med, Taegu, South Korea

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2230

引用

页码：S944 / S945

页数：2

共 50 条

[31] POLYMORPHISM OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AT POSITION -308 IN RELATION TO ANKYLOSING-SPONDYLITIS [J].

VERJANS, GMGM ;

BRINKMAN, BMN ;

VANDOORNIK, CEM ;

KIJLSTRA, A ;

VERWEIJ, CL .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (01) :45-47

[32] SHORT-TERM RESPONSE PREDICTS LONG-TERM OUTCOME AND DISCONTINUATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TNF BLOCKERS [J].

Baraliakos, X. ;

Listing, J. ;

Fritz, C. ;

Sieper, J. ;

Braun, J. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) :617-617

[33] Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers [J].

Nam, Eon Jeong ;

Lee, Won Kee .

MEDICINE, 2020, 99 (41) :E22668

[34] TNF-ALPHA INHIBITION - IMPROVEMENT IN CLINICAL OUTCOME OF ISHAEMIC STROKE [J].

Chatterjee, D. ;

Wijenayake, I. ;

Rangasamy, R. ;

Nevajda, B. .

INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) :695-695

[35] TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients [J].

Miranda-Filloy, J. A. ;

Llorca, J. ;

Carnero-Lopez, B. ;

Gonzalez-Juanatey, C. ;

Blanco, R. ;

Gonzalez-Gay, M. A. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (06) :850-855

[36] DETERMINANTS OF 12-MONTHS PERSISTENCE IN ANKYLOSING SPONDYLITIS PATIENTS INITIATING SUBCUTANEOUS TNF-ALPHA INHIBITORS [J].

Fautrel, B. ;

Belhassen, M. ;

Hudry, C. ;

Woronoff, M. -C. ;

Gouyette, N. ;

Clement, A. ;

Van Ganse, E. ;

Tubach, F. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :754-755

[37] TRANSGENIC MICE EXPRESSING A TRUNCATED TNF-ALPHA GENE MANIFEST AN ARTHRITIS RESEMBLING ANKYLOSING-SPONDYLITIS [J].

BRAHN, E ;

CREW, MD ;

EFFROS, RB ;

WALFORD, RL ;

ZELLER, E ;

CHEROUTRE, H .

ARTHRITIS AND RHEUMATISM, 1995, 38 (09) :480-480

[38] Anti-TNF-alpha therapy causes upregulation of HLA-B27 expression in patients with ankylosing spondylitis. [J].

Wittwer, H ;

Gruber, R ;

Landauer, N ;

Koroknay, A ;

Schattenkirchner, M ;

Kellner, H .

ARTHRITIS AND RHEUMATISM, 2001, 44 (09) :S90-S90

[39] TNF-alpha and IL-17 cytokine levels in Brazilian patients with ankylosing spondylitis after anti-TNF therapy [J].

Lara-Armi, Fernanda Formaggi ;

Visentainer, Jeane Eliete Laguila ;

Braga, Matheus ;

Zacarias, Joana Maira Valentini ;

Rocha-Loures, Marco Antonio ;

Neves, Janisleya Silva Ferreira ;

Moliterno, Ricardo Alberto ;

Sell, Ana Maria .

BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59

[40] Two year follow up results of a controlled trial of the anti-TNF alpha antibody infliximab in active ankylosing spondylitis. [J].

Brandt, J ;

Listing, J ;

Alten, R ;

Bumester, G ;

Gromnica-Ihle, E ;

Kellner, H ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Sieper, J ;

Braun, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S172-S173

← 1 2 3 4 5 →